The others publications

Kuopio 75+

Hiltunen M, Kerola T, Kettunen R, Hartikainen S, Sulkava R, Vuolteenaho O, Nieminen T. The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age. Ann Med 2012;45:74-78.

Kerola T, Nieminen T, Sulkava R, Vuolteenaho O, Hartikainen S, Kettunen R. Inverted mitral inflow pattern in echocardiography among the elderly – a marker of non-cardiovascular mortality and cognitive dysfunction. Int J Cardiol 2012;155:70-4.

Kerola T, Hiltunen M, Kettunen R, Hartikainen S, Sulkava R, Vuolteenaho O, Nieminen T. Mini-Mental State Examination Score and B-type Natriuretic Peptide as Predictors of Cardiovascular and Total Mortality in an Elderly General Population. Ann Med 2011;43:650-9.

Tuikkala P, Hartikainen S, Korhonen MJ, Sulkava R, Enlund H. Serum total cholesterol levels and all-cause mortality in a home-dweling elderly population: a six-year follow-up. Scandinavian J Prim Health Care. 2010;28:121-7

Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, Kettunen R. B-type natriuretic peptide as a predictor of declining cognitive function and dementia – a cohort study of an elderly general population with a 5-year follow-up.  Ann Med 2010;42:207-15

Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, Kettunen R. High-density lipoprotein is superior to B-type natriuretic peptide as a marker of systolic dysfunction in an elderly general population. Scan J Clin Lab Invest 2009;69:865-72.

Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of  mortality in an elderly population. Drugs Aging 2009;26:1039-48.

Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of Drug Use and Factors Associated with Polypharmacy and Excessive Polypharmacy in Elderly Persons: Results of the Kuopio 75+ Study. Drugs Aging 2009; 26:493-503.

Syrjälä A-M, Ylöstalo P, Hartikainen S, Sulkava R, Knuuttila M. Number of teeth and selected cardiovascular risk factors among elderly people. Gerodontology 2010; 27:189-92.

Syrjälä A-M, Ylöstalo P, Hartikainen S, Sulkava R, Knuuttila M. Number of teeth and myocardial infarction and stroke among elderly never smokers.J Negative Results BioMedicine 2009;8:6

Hiitola P, Enlund H, Sulkava R, Hartikainen S. Changes in the use of cardiovascular medicines in the Elderly aged 75 years or more – A Population-based Kuopio 75+ Study. J Clin Pharm Ther 2007;32:253-259

Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H.The increasing use of medicines in elderly persons: a follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacology 2006; 62:151-158.

Aira M, Hartikainen S, Sulkava R. Community prevalence of alcohol use and concomitant use of medication – a source of possible risk in the elderly aged 75 and older? Int J Geriatr Psychiatry  2005; 20:680-685

Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. The Use of Psychotropics and  Survival in Demented Elderly Persons.Inter Clin Psychopharmacol 2005; 20:227-231

Hartikainen S, Mäntyselkä P, Louhivuori-Laako K, Enlund H,  Sulkava R. Concomitant use of analgesics and psychotropics in home-dwelling elderly people - Kuopio 75 + study Britt J of Clinical Pharmacology 2005;60:306-310.

Hartikainen S, Mäntyselkä P, Louhivuori- Laako K, Sulkava R. Balancing with pain and analgesic drug treatment in the home-dwelling elderly. Ann Pharmacotherapy 2005; 39:11-16

Kauppi M, Hartikainen S, Kautiainen H, Laiho K, Sulkava R. Capability for daily activities in old people with rheumatoid arthritis – a population based study. Ann Rheum Dis. 2005;64:56-58.

Mäntyselkä P, Hartikainen S, Louhivuori- Laako K, Sulkava R. Effects of Dementia on Perceived Daily Pain Among Home-Dwelling Elderly People: Population Based Study.Age Ageing 2004; 33:496-499

Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry 2003; 18:1135-1141

Hartikainen S, Rahkonen T, Kautiainen H, Sulkava R. Kuopio 75 + study: Does advanced age predict more common use of psychotropics among the elderly? Inter Clin Psychopharmacol 2003; 18:163-7.

Leppävirta

Gisev N, Hartikainen S, Chen TF, Korhonen M, Bell JS. Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults. Int Psychogeriatr 2012 Jul;24(7):1058-64.

Gisev N, Hartikainen S, Chen T, Korhonen M, Bell JS.  Mortality associated with  benzodiazepines and related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study. Can J Psychiatry 2011;56:377-81

Bell S, Lavikainen P, Korhonen M, Hartikainen S. Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study. Eur J Clin Pharmacol 2011; 67: 105-106.

Ahonen J, Bell S, Hartikainen S. Fentanyylilaastarien käyttö kotona asuvien vanhusten hoidossa herättää huolta. Suom Lääkäril 2010; 65: 2179-83.

Tuunanen J, Bell S, Korhonen M, Silvasti M, Hartikainen S. Vanhusten uni- ja rauhoittavien lääkkeiden käyttöä voidaan vähentää. Suom Lääkäril (Finnish Medical Journal) 2010; 65: 1449-52.

Hartikainen S, Lavikainen P, Raunio H, Ahonen J, Peura P, Martikainen J, Klaukka T. Mahahaavalääkitys pienemmin kustannuksin. Suom Lääkäril (Finnish Medical Journal) 2009: 64: 296-99.

Korhonen MJ, Hartikainen S. Löytyykö potilaan lääkitys sähköisestä sairauskertomuksesta? Suom Lääkäril (Finnish Medical Journal) 2009; 64: 60-62.

Korhonen M, Klaukka T, Lönnroos E, Hartikainen S. Satavuotiaidenkin lääkityksessä usein korjattavaa. Suom Lääkäril 2008; 63: 3436-8.

Klaukka T, Hartikainen S. Alzheimer-lääkkeiden käyttö yleistyy edelleen. Suom Lääkäril (Finnish Medical Journal) 2006; 61: 3978-3980.

the others

Rantala M, Kankkunen P, Kvist T, Hartikainen S. Post-operative management practices in patients with dementia -  the current situation in Finland. Open Nurs J. 2012;6:71-81.

Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Møller H; Diabetes and Cancer Research Consortium. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 2012 Jun;55(6):1619-32.

Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG; Diabetes and Cancer Research Consortium. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 2012 Jun;55(6):1607-18.

Hartikainen S, Bell JS. Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures. Evid Based Ment Health 2011 Nov;14(4):111.

Lamb SE, Becker C, Gillespie LD, Smith JL, Finnegan S, Potter R, Pfeiffer K; Taxonomy Investigators. Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials 2011 May 17;12:125.

Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkälä KH. Use of proton-pump inhibitors and mortality among institutionalized older people. Archives of Internal Medicine 2010;170:1604-1605

O'Reilly CL, Bell JS, Chen TF. Mental health consumer educators for pharmacy students: impacts on stigma and attitudes towards provision of pharmaceutical services. American Journal of Pharmaceutical Education 2010; 74;article 167

Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Drug-related problems in Australian aged care homes: impact of collaborative medication reviews involving pharmacists and general practitioners. Journal of Evaluation in Clinical Practice 2010 Sept 2 [Epub ahead of print] DOI: 10.1111/j.1365-2753.2010.01374.x

Volmer D, Lilja J, Hamilton D, Bell JS, Veski P. Self-reported competence of Estonian community pharmacists in relation to herbal products: findings from a health-system in transition. Phytother Res 2011;25:381-6.

Aaltonen SE, Laine NP, Volmer D, Gharat MS, Muceniece R, Vitola A, Foulon V, Desplenter FA, Airaksinen MS, Chen TF, Bell JS. Barriers to medication counselling for people with mental disorders: a six country study. Pharmacy Practice 2010:8;122-131

Kumpula E-K, Bell JS, Soini H, Pitkälä KH. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol 2011;51:256-63.

Pohjanoksa-Mäntylä M, Bell JS, Närhi U, Helakorpi S, Lehtonen A, Airaksinen MS. Is the internet replacing health professionals? A population survey of drug information sources among people with mental disorders. Soc Psychiatry Psychiatr Epidemiol 2011;46:373-9.

Panthee S, Panthee B, Shakya SR, Panthee N, Bhandari DR, Bell JS. A national survey of the perceived impact of mental disorders on pharmacy education in Nepal. Am J Pharm Educ 2010;74:89. 

Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Determinants of antipsychotic medication use among older people living in aged care homes in Australia. International Journal of Geriatric Psychiatry 2010; 25:449-57

Foulon V, Svala A, Koskinen H, Chen TF, Saastamoinen LK, Bell JS. Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland. Journal of Child and Adolescent Psychopharmacology 2010;20:145-150

Gisev N, Bell JS, O'Reilly CL, Rosen A, Chen TF. An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Social Psychiatry and Psychiatric Epidemiology 2010; 45:1071-9

Bell JS, Taipale HT, Soini H, Pitkälä KH. Sedative load among long-term care facility residents with and without dementia: a cross-sectional study. Clinical Drug Investigation 2010;30:63-70

Westerling A, Haikala V, Bell JS, Airaksinen MS. Logistics or patient care – which features do independent Finnish pharmacy owners prioritize in a strategic plan for future information technology systems? Journal of the American Pharmacists Association 2010;50:24-31

Bell JS, Aaltonen SE, Airaksinen MS, Volmer D, Gharat MS, Muceniece R, Vitola A, Foulon V, Desplenter FA, Chen TF. Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia.  International Journal of Social Psychiatry 2010;56:3-14

Taipale HT, Hartikainen S, Bell JS. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. American Journal of Geriatric Pharmacotherapy 2010;8:460-71
 
Bell JS, Enlund H, Vainio K. Medication adherence: a review of education, research, practice and policy in Finland. Pharmacy Practice 2010;8:147-161

Lampela P, Forsberg MM, Bell JS, Hartikainen S. Antikolinergisen vaikutuksen arviointi iäkkäillä on vaikeaa. Evaluation of anticholinergic activity is challenging among older people. Suomen Lääkärilehti/Finnish Medical Journal 2010; 65:3202-3203

Bell JS. Optimising medication treatment for older people: an overview of recent developments in Australia. Dosis 2010;26:13-19

Bell JS, Hartikainen S. Comment on: Is pharmacy reader for the baby boomers? by Hanlon JT [letter]. American Journal of Geriatric Pharmacotherapy 2010;8:1-2